Phio Pharmaceuticals Corp (NASDAQ:PHIO) has a beta value of 1.46 and has seen 0.78 million shares traded in the recent trading session. The company, currently valued at $2.84M, closed the recent trade at $3.30 per share which meant it gained $0.54 on the day or 19.57% during that session. The PHIO stock price is -470.0% off its 52-week high price of $18.81 and 27.27% above the 52-week low of $2.40. If we look at the company’s 10-day average daily trading volume, we find that it stood at 80590.0 shares traded. The 3-month trading volume is 57.70K shares.
Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information
Sporting 19.57% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PHIO stock price touched $3.30 or saw a rise of 14.95%. Year-to-date, Phio Pharmaceuticals Corp shares have moved -51.75%, while the 5-day performance has seen it change 14.19%. Over the past 30 days, the shares of Phio Pharmaceuticals Corp (NASDAQ:PHIO) have changed -10.70%. Short interest in the company has seen 48277.0 shares shorted with days to cover at 1.06.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Phio Pharmaceuticals Corp (PHIO) estimates and forecasts
The company’s shares have lost -43.50% over the past 6 months, compared to 17.60% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 62.38% over the past 5 years.
PHIO Dividends
Phio Pharmaceuticals Corp is expected to release its next earnings report on 2024-Nov-07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders
Insiders own 5.89% of the company shares, while shares held by institutions stand at 2.56% with a share float percentage of 2.72%. Investors are also buoyed by the number of investors in a company, with Phio Pharmaceuticals Corp having a total of 13.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. As of Aug 31, 2024, the former fund manager holds about 0.75% shares in the company for having 6.47 shares of worth $21040.0 while later fund manager owns 2.71 shares of worth $8804.0 as of Jun 30, 2024, which makes it owner of about 0.31% of company’s outstanding stock.
